Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib

doi:10.3748/wjg.v24.i28.3155

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6493)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

497

HTML

3407

Figures (1-1)

240

Tables (1-4)

245

Sum=4389

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

955

Download

1149

Sum=2104

Jul 28, 2018 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 28, 2018; 24(28): 3155-3162
Published online Jul 28, 2018. doi: 10.3748/wjg.v24.i28.3155

Table 1 Baseline characteristics of patients

Patient features	n (%)
Total No. of patients	40
Age (yr)
Median (range)	71 (48-89)
Sex
Male	31 (78)
Female	9 (12)
Child-Pugh class
A	36 (90)
B	4 (10)
Underlying cause
HCV	23 (58)
HBV	10 (25)
Others	7 (17)
Portal vein thrombosis	11 (28)
Liver only	26 (60)
Metastatic disease	24 (40)
AFP (ng/mL)
> 100	26 (65)
≤ 100	14 (35)
DCP (mAU/mL)
> 1000	19 (48)
≤ 1000	21 (52)
BCLC stage
B	16 (40)
C	24 (60)
Intervention by pharmacists
Yes	22 (55)
No	18 (45)

AFP: Alpha-fetoprotein; BCLC: Barcelona Clinic Liver Cancer; DCP: Des-gamma-carboxy prothrombin; HCV: Hepatitis C virus; HBV: Hepatitis B virus.

Citation: Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2018; 24(28): 3155-3162
URL: https://www.wjgnet.com/1007-9327/full/v24/i28/3155.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i28.3155